FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

34746711000001103: Carbocisteine 250mg/5ml oral solution (Typharm Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Oct 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105085501000001114 Carbocisteine 250mg/5ml oral solution (Typharm Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105085601000001113 Carbocisteine 250mg/5ml oral solution (Typharm Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) Is a Carbocisteine 250mg/5ml oral solution true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) Is a Carbocysteine 250mg/5mL syrup false Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) Has active ingredient Carbocisteine true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) Has manufactured dose form Conventional release oral syrup true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) Has specific active ingredient Carbocisteine true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) Is a Carbocisteine 250mg/5ml oral solution false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Carbocisteine 250mg/5ml oral solution (Typharm Ltd) 300 ml Has AMP True Carbocisteine 250mg/5ml oral solution (Typharm Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start